Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors

This publication has 364 references indexed in Scilit:

• Prognostic significance of serum c-erbB-2 protein in breast cancer patients
  Breast Cancer Research and Treatment, 1996
• ErbB Receptor Activation, Cell Morphology Changes, and Apoptosis Induced by Anti-Her2 Monoclonal Antibodies
  Biochemical and Biophysical Research Communications, 1996
• Theneu oncogene product in serum and tissue of patients with metastatic gastrointestinal carcinomas
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1996
• Multivariate survival analysis of clinicopathologic features in surgical stage I endometrioid carcinoma including analysis of HER-2/neu expression
  American Journal of Obstetrics and Gynecology, 1995
• Prognostic indicators for neuroblastoma: Stage, grade, DNA ploidy, MIB‐1‐proliferation index, p53, HER‐2/neu and EGFr–a survival study
  Journal of Surgical Oncology, 1995
• Carcinoma of the male breast: Update 1994
  Medical and Pediatric Oncology, 1995
• Coexpression of HER-2/neu and p53 is associated with a shorter disease-free survival in node-positive breast cancer patients
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1994
• NDF/heregulin stimulates the phosphorylation of Her3/erbB3
  FEBS Letters, 1994
• Cloning and Expression of cDNA Encoding Human Betacellulin, a New Member of the EGF Family
  Biochemical and Biophysical Research Communications, 1993
• Estrogen suppression of erbB2 expression is associated with increased growth rate of ZR‐75‐1 human breast cancer cells in vitro and in nude mice
  International Journal of Cancer, 1991